395 related articles for article (PubMed ID: 12466740)
1. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
Kaunitz AM;
Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
[No Abstract] [Full Text] [Related]
2. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
Hendrix SL
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
[No Abstract] [Full Text] [Related]
3. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
Henriksson P
Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
[No Abstract] [Full Text] [Related]
4. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
5. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
6. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
Randolph JF;
Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
[No Abstract] [Full Text] [Related]
7. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
9. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
von Schoultz B
Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
[No Abstract] [Full Text] [Related]
10. HRT: forever or never?
Corson SL
Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
[No Abstract] [Full Text] [Related]
11. Good science or good marketing?
Head K
Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
[No Abstract] [Full Text] [Related]
12. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.
van der Mooren MJ; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):123-4. PubMed ID: 12648855
[No Abstract] [Full Text] [Related]
14. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
Walsh BW
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
[No Abstract] [Full Text] [Related]
15. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
16. Women's health. The vanishing promises of hormone replacement.
Enserink M
Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
[No Abstract] [Full Text] [Related]
17. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
18. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
American Medical Association
Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
[No Abstract] [Full Text] [Related]
19. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
[No Abstract] [Full Text] [Related]
20. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
